Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials.
Tofte SJ, Papp K, Sadick N, Bohnert K, Simpson E, Thaçi D, Bieber T, Blauvelt A, Sofen H, Gooderham M, Chen Z, Gadkari A, Eckert L, Graham NMH, Pirozzi G, Ardeleanu M. Tofte SJ, et al. Among authors: thaci d. J Am Assoc Nurse Pract. 2018 Sep;30(9):529-541. doi: 10.1097/JXX.0000000000000088. J Am Assoc Nurse Pract. 2018. PMID: 30211823 Clinical Trial.
The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled study.
Foelster Holst R, Reitamo S, Yankova R, Worm M, Kadurina M, Thaci D, Bieber T, Tsankov N, Enk A, Luger T, Duffy M, Tansley R. Foelster Holst R, et al. Among authors: thaci d. Allergy. 2010 Dec;65(12):1594-9. doi: 10.1111/j.1398-9995.2010.02417.x. Epub 2010 Sep 7. Allergy. 2010. PMID: 21039597 Clinical Trial.
Perioral dermatitis.
Wollenberg A, Bieber T, Dirschka T, Luger T, Meurer M, Proksch E, Schön MP, Schwarz T, Thaçi D, Zuberbier T, Werfel T; German Society of Dermatology. Wollenberg A, et al. Among authors: thaci d. J Dtsch Dermatol Ges. 2011 May;9(5):422-7. doi: 10.1111/j.1610-0387.2010.07329.x. Epub 2010 Oct 8. J Dtsch Dermatol Ges. 2011. PMID: 21040469 English, German. No abstract available.
Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract--a new therapeutic option for patients with atopic dermatitis.
Novak N, Thaci D, Hoffmann M, Fölster-Holst R, Biedermann T, Homey B, Schaekel K, Stefan JA, Werfel T, Bieber T, Sager A, Zuberbier T. Novak N, et al. Among authors: thaci d. Int Arch Allergy Immunol. 2011;155(3):252-6. doi: 10.1159/000320058. Epub 2011 Feb 2. Int Arch Allergy Immunol. 2011. PMID: 21293143 Clinical Trial.
Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study.
Papp KA, Kaufmann R, Thaçi D, Hu C, Sutherland D, Rohane P. Papp KA, et al. Among authors: thaci d. J Eur Acad Dermatol Venereol. 2013 Mar;27(3):e376-83. doi: 10.1111/j.1468-3083.2012.04716.x. Epub 2012 Oct 3. J Eur Acad Dermatol Venereol. 2013. PMID: 23030767 Clinical Trial.
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.
McInnes IB, Kavanaugh A, Gottlieb AB, Puig L, Rahman P, Ritchlin C, Brodmerkel C, Li S, Wang Y, Mendelsohn AM, Doyle MK; PSUMMIT 1 Study Group. McInnes IB, et al. Lancet. 2013 Aug 31;382(9894):780-9. doi: 10.1016/S0140-6736(13)60594-2. Epub 2013 Jun 13. Lancet. 2013. PMID: 23769296 Clinical Trial.
329 results